[Organ preservation after short-course radiotherapy and transanal endoscopic microsurgery for early-stage rectal cancer (TREC)]

[Article in German]

Affiliations

¹ Chirurgische Universitätsklinik, UKSH, Campus Kiel, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland. Julius.Pochhammer@uksh.de.
² Klinik für Strahlentherapie, UKSH, Campus Kiel, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland.

Comment

[Article in German]

Julius Pochhammer et al. Strahlenther Onkol. 2021 Aug.

. 2021 Aug;197(8):749-751.

doi: 10.1007/s00066-021-01795-0. Epub 2021 Jun 4.

¹ Chirurgische Universitätsklinik, UKSH, Campus Kiel, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland. Julius.Pochhammer@uksh.de.
² Klinik für Strahlentherapie, UKSH, Campus Kiel, Arnold-Heller-Str. 3, 24105, Kiel, Deutschland.

No abstract available

Comment on

Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study.
Bach SP, Gilbert A, Brock K, Korsgen S, Geh I, Hill J, Gill T, Hainsworth P, Tutton MG, Khan J, Robinson J, Steward M, Cunningham C, Levy B, Beveridge A, Handley K, Kaur M, Marchevsky N, Magill L, Russell A, Quirke P, West NP, Sebag-Montefiore D; TREC collaborators. Bach SP, et al. Lancet Gastroenterol Hepatol. 2021 Feb;6(2):92-105. doi: 10.1016/S2468-1253(20)30333-2. Epub 2020 Dec 11. Lancet Gastroenterol Hepatol. 2021. PMID: 33308452 Free PMC article. Clinical Trial.

1. Bach SP, Gilbert A, Brock K, et al. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Lancet Gastroenterol Hepatol. 2020;6:92–105. doi: 10.1016/S2468-1253(20)30333-2. - DOI - PMC - PubMed
1. Boyle J, Braun M, Hill J et al (2018) National Bowel Cancer Audit: annual report 2018. https://www.nboca.org.uk/reports/annual-report-2018/. Zugegriffen: 28. Okt. 2020
1. Garcia-Aguilar J, Renfro LA, Chow OS, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015;16:1537–1546. doi: 10.1016/S1470-2045(15)00215-6. - DOI - PMC - PubMed
1. Peters FP, Teo MTW, Appelt AL, et al. Mesorectal radiotherapy for early stage rectal cancer: a novel target volume. Clin Transl Radiat Oncol. 2020;21:104–111. doi: 10.1016/j.ctro.2020.02.001. - DOI - PMC - PubMed
1. Quezada-Diaz FF, Smith JJ, Jimenez-Rodriguez RM. Patient-reported bowel function in patients with rectal cancer managed by a watch-and-wait strategy after neoadjuvant therapy: a case-control study. Dis Colon Rectum. 2020;63:897–902. doi: 10.1097/DCR.0000000000001646. - DOI - PMC - PubMed